It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …

Adrenocortical carcinoma (ACC) is a rare, heterogenous and highly malignant disease.
Management of ACC is dependent on disease stage with complete surgical resection as the …

Adrenal cortical carcinoma (ACC) is a rare and aggressive malignancy that poses
challenging issues regarding the diagnostic workup. Indeed, no presurgical technique or …

Increasing evidence confirms that tumor microenvironment (TME) can influence tumor
progression and treatment, but TME is still understudied in adrenocortical carcinoma (ACC) …

Simple Summary Adrenocortical cancer (ACC) is a rare malignancy, often diagnosed late
and with a poor prognosis. Currently, ACC best management is achieved in referral centers …

Background. Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. An accurate
diagnosis of ACC is of paramount importance as it greatly impacts the management and …

Being a rare malignancy, adrenocortical carcinoma (ACC) exhibits aggressiveness and poor
prognosis. Fibronectin type III domain‑containing protein 5 (FNDC5) is a transmembrane …

Methods A working group established by ESES reviewed the current guidelines and
undertook a literature search of the PubMed database focused on several clinical questions …

The outcomes of patients with genitourinary (GU) cancers have been steadily improving in
recent years. Novel therapies have entered our armamentarium, while several other …

目的: 探索Ki-67 指数对肾上腺皮质癌(ACC) 术后预后的预测价值. 方法: 分析2010 年1 月—
2018 年1 月经术后病理证实的40 例ACC 患者临床及病理数据. 将其分为存活组和死亡组 …